Nutrition, Metabolic & Cognitive Neuroscience · · 22 min read · By

Dihexa for Keto & Low-Carb Brain Fog: Ketones, the Keto Flu, BHB & the 2026 UK Review

Dihexa for keto and low-carb brain fog - 2026 UK evidence review illustration showing the glucose-to-ketone fuel switch and BHB

Keto is sold as a shortcut to mental clarity — yet “keto brain fog” is one of the most-searched complaints in the whole low-carb world. Both things are true at once, which is exactly why it confuses people. Cut carbohydrate hard and, for the first week or two, many feel foggy, flat and slow — the notorious “keto flu.” Push through and a lot of people report the opposite: steady, spike-free focus. A 2026 study of three weeks of keto in students caught the paradox neatly — participants got faster but less accurate. So what is really going on, is keto brain fog dangerous, and where — if anywhere — does a synaptogenic peptide like Dihexa fit? This 2026 UK review separates the transient electrolyte problem from the deeper ketone-and-cognition science, follows the elegant beta-hydroxybutyrate–BDNF story to its honest limits, and explains why an unlicensed research chemical is the wrong answer to a fog that usually clears with salt and time.

Not medical advice. Dihexa (PNB-0408) is an unscheduled research chemical, not an approved treatment for brain fog or any other condition. Ketogenic and low-carb diets are dietary approaches, not medicines, and are not suitable for everyone — anyone with type 1 diabetes, on diabetes or blood-pressure medication, pregnant, or with a history of eating disorders should get medical advice before starting. This page is general information, not a recommendation to adopt any diet or take any product. If you have persistent brain fog, the right first step is a proper assessment with your GP to rule out treatable causes. Read the full legal disclaimer.

Key Findings: Keto & Low-Carb Brain Fog vs Dihexa

  • Two separate phenomena: The early “keto flu” fog is a transient electrolyte problem; the longer-term ketone-cognition question is a different, deeper story. Confusing them is the root of most keto brain-fog myths.
  • Keto flu is usually self-limiting: A 2025 scoping review found symptoms typically start within 2–3 days and resolve within 2–4 weeks, driven mostly by sodium and fluid loss — not brain damage.
  • The fix is salt, not a peptide: Falling insulin makes the kidneys dump sodium; replacing fluids and electrolytes (especially sodium, plus magnesium and potassium) often relieves fog within 30–90 minutes.
  • Ketones as brain fuel: In mild cognitive impairment and Alzheimer’s, brain glucose use falls; ketones can bypass that deficit, and a 2026 meta-analysis reports modest cognitive signals, strongest in these groups.
  • In healthy people it’s mixed: The 2026 student study found keto made cognition faster but less accurate — a real trade-off, not a clean win.
  • The BHB–BDNF twist: Beta-hydroxybutyrate is a natural HDAC inhibitor that switches on BDNF in rodent hippocampus (Sleiman 2016) — but a 2025 human study found no BDNF or cognition benefit in people.
  • A prolonged-keto caution: A Neurology case report described reversible memory and attention problems on long-term strict keto, which improved when carbs were reintroduced.
  • Where Dihexa stands: No completed human trial for brain fog; a pre-clinical-only HGF/c-Met case; a pro-proliferative c-Met concern; and a closest clinical relative, fosgonimeton, that failed its Alzheimer’s Phase 3.
  • Bottom line: Keto brain fog is common, usually temporary and cheaply fixable. Sort the electrolytes, give adaptation two weeks, treat any underlying cause — and leave the unlicensed peptide out of it.

The Keto Paradox: A Clarity Diet With a Fog Problem

Few diets carry a contradiction as sharp as keto’s. Its advocates promise laser focus and “mental clarity” from running the brain on ketones instead of glucose. And yet type “keto” into a search bar and one of the first suggestions is “keto brain fog.” Both experiences are genuine, and the confusion comes from lumping them together. There are really two different things going on: a short, self-limiting adjustment symptom at the start, and a longer-run question about what a carbohydrate-restricted, ketone-fuelled brain actually does over weeks and months. Get those two apart and almost everything about keto brain fog becomes clear.

This matters for our purposes because the low-carb world overlaps heavily with the nootropic and biohacking communities where Dihexa circulates. Someone a week into keto, foggy and irritable, googling for a fix, can easily end up reading about a “synaptogenic” peptide as if it were the answer. It is not — and understanding the actual biology of keto fog shows why the honest fix is almost always cheaper, safer and already in your kitchen cupboard.

Part One: The “Keto Flu” — Why the First Fortnight Feels Foggy

When you drop carbohydrate below roughly 20–50 g a day, your body has to switch its primary fuel from glucose to fat-derived ketones. That metabolic switch is not instant, and during the changeover many people feel genuinely rough: headache, fatigue, light-headedness, irritability, muscle cramps and a distinct mental fog often lumped together as the “keto flu.” A 2025 scoping review of keto-initiation symptoms found they typically appear within 2–3 days of starting and, for most people, resolve within 2–4 weeks — rarely severe enough to warrant stopping.

Crucially, the fog is mostly not about the brain being starved of fuel. It is largely about water and electrolytes. Cutting carbs lowers insulin, and lower insulin tells the kidneys to excrete more sodium and water. As sodium drops, so do fluid volume and, with them, blood pressure and cerebral perfusion — the exact recipe for a foggy, light-headed, low-battery feeling. This is the same fluid-and-electrolyte theme that runs through our review of dehydration and heat brain fog: the brain is exquisitely sensitive to how well it is perfused.

Fixing keto flu: salt, fluids, magnesium, time

Because the mechanism is electrolyte loss, the fix is electrolyte replacement. The most reliable lever is sodium: many low-carb clinicians suggest markedly higher salt intake during adaptation than the general guideline, via salted food, broth or electrolyte drinks. Add adequate potassium and magnesium (low magnesium worsens cramps and fog), keep well hydrated, ease off hard training for a week or two, and protect your sleep. People often notice the fog lift within 30–90 minutes of salted fluids — a useful clue that electrolytes, not carbohydrate withdrawal itself, were the problem.

The simple version. Early keto brain fog is usually a plumbing problem, not a wiring problem. You are low on salt and water, not short of synapses. That is why a pinch of salt and a fortnight of patience beats anything you could buy in a vial.

Part Two: Ketones as Brain Fuel — the Deeper Story

Once you are past adaptation, the interesting question begins: is a ketone-fuelled brain actually better, worse, or just different? Here the biology is genuinely compelling. The main ketone, beta-hydroxybutyrate (BHB), is not merely an emergency fuel; it is a clean, efficient one that many neurons happily burn. The strongest case for ketones helping cognition comes from brains that struggle to use glucose in the first place.

In mild cognitive impairment (MCI) and Alzheimer’s disease, specific brain regions become glucose-hypometabolic — they can no longer take up and burn sugar efficiently, an “energy gap” that appears early in the disease. Ketones can slip past that defect and fuel the neurons directly. That is the rationale behind a growing set of trials: a randomised feasibility trial of the modified Atkins diet in older adults with MCI due to Alzheimer’s, ketogenic medium-chain-triglyceride studies, and exogenous-ketone drinks. A 2026 systematic review and meta-analysis in Frontiers in Nutrition pulled the exogenous-ketone trials together and found modest cognitive benefits, most consistent in people with MCI or Alzheimer’s and in those negative for the APOE4 risk gene.

But the honest reading is cautious. The clinical trials are small and heterogeneous, mixing different populations and ketone sources, and the effects are modest. In healthy brains — which have plenty of glucose — the added value of ketones is much less clear. The 2026 study of three weeks of keto in undergraduates captured this trade-off perfectly: participants performed cognitive tests faster at follow-up, with gains in visual-motor and processing speed, but were less accurate on the harder working-memory tasks. “Faster but less accurate” is not the unambiguous upgrade the marketing implies.

The BHB–BDNF Bridge — Where Keto Meets the Dihexa Story

This is where the ketone story brushes up against the very mechanism this site exists to scrutinise. Beyond being a fuel, BHB is a signalling molecule. It is a natural inhibitor of class I histone deacetylases (HDACs) — enzymes that keep genes switched off by tightening how DNA is packaged. Inhibit them, and certain genes get read more readily. And one of the genes BHB de-represses in the hippocampus is the gene for brain-derived neurotrophic factor (BDNF), the master regulator of synaptic plasticity that recurs throughout this blog.

The landmark work here is Sleiman and colleagues (eLife, 2016), who showed that exercise drives BHB into the hippocampus, where it inhibits HDAC2 and HDAC3 and specifically induces BDNF — a tidy molecular explanation for part of why exercise is good for the brain. More recent work, such as a 2024 Cell Chemical Biology paper, positions BHB as a broader metabolic regulator of protein quality-control in the aged and Alzheimer’s brain. On paper, then, ketosis and Dihexa are chasing an overlapping prize: more BDNF, better plasticity, healthier synapses.

The honest caveat that matters most. The elegant BHB–BDNF story is largely a rodent story. A 2025 study in American Journal of Physiology – Cell Physiology gave exogenous BHB to humans with type 2 diabetes and to insulin-resistant rodents and found that, in people, raising BHB did not increase BDNF or improve cognition — even though it usefully modulated an amyloid-processing enzyme (BACE1) in mice. The mechanism is real; the human payoff is not yet demonstrated.

That caveat is the whole point. It is the same trap Dihexa falls into, only one step further along: a beautiful, plausible plasticity mechanism that looks powerful in animals and thins out dramatically when tested in people. If raising ketones — a natural, well-tolerated intervention — cannot reliably lift human BDNF or cognition, it should make anyone deeply sceptical of grander claims for an unlicensed peptide acting on a parallel pathway.

The Other Side: When Keto Itself Causes Fog

Keto is not universally pro-cognition, and it is worth being even-handed. A case report in Neurology described a person who developed reversible memory loss, attention problems and executive-function difficulties associated with prolonged, strict ketogenic dieting — and importantly, these improved when carbohydrate was reintroduced. A single case does not make a rule, but it is a real signal that very long-term, rigid keto can, in some people, become part of the problem rather than the solution.

There are plausible contributors: chronically low electrolytes, missing micronutrients on a poorly formulated keto diet, under-eating, disrupted sleep, and the stress of extreme restriction. The wider point for the “carnivore” and hardcore-keto crowd is that more restriction is not automatically more clarity. If your fog got worse the longer you stayed strict, that is a reason to reassess the diet — not to add an experimental research chemical on top of it.

Low-Carb, Blood Sugar & the Metabolic Route to Clearer Thinking

There is one setting where cutting carbohydrate has strong, non-controversial evidence and a plausible line to cognition: metabolic health. High and unstable blood glucose is itself a driver of fog and fatigue, and low-carbohydrate eating is an established tool for type 2 diabetes. A 2025 systematic review of low-carb diets in type 2 diabetes remission found remission rates as high as around 62% at one year — though, importantly, the benefit faded over time, falling to roughly 13% by five years. Diabetes UK and the NHS accept lower-carb eating (commonly framed as 50–130 g carbohydrate a day) as one reasonable, clinician-supported option, and HEART UK offers a balanced overview of the heart-health considerations.

By steadying blood sugar and cutting the post-meal spike-and-crash cycle, low-carb eating can indirectly lift the metabolic fog that plagues many people with insulin resistance — a mechanism this site also touches on in its reviews of ultra-processed food and the gut-brain axis. It is worth noting the picture is not one-directional: some 2026 data suggest blood-sugar control can drift after several years on very strict keto, and in 2026 GLP-1 medicines such as semaglutide and tirzepatide have become another established route to diabetes remission. The through-line is simple: treating the metabolic problem is what helps the brain — not a peptide bolted on top.

Where Dihexa Enters — and Why It Does Not Belong Here

Dihexa (PNB-0408) is a small peptide derived from angiotensin IV, developed as a positive modulator of the HGF/c-Met pathway. Hepatocyte growth factor (HGF), acting on its c-Met receptor, drives synaptogenesis — the building of new synaptic connections — and MET signalling remains active in the adult hippocampus and prefrontal cortex. In the foundational Benoist 2014 JPET study, Dihexa improved learning in rodents, with effects that depended on the HGF/Met system. Conceptually, it aims at the same destination as the BHB–BDNF pathway: more plasticity, more synapses. The mechanism of action page covers the biology in depth.

But notice the pattern this whole review has traced. Ketones are a natural, well-tolerated intervention with a genuine plasticity mechanism — and even they struggle to show a reliable human BDNF or cognition benefit. Dihexa asks you to accept a larger claim on less evidence: there is no completed, published human efficacy trial of Dihexa for brain fog, keto-related or otherwise. And it carries a risk ketones do not: its mechanism amplifies the pro-proliferative c-Met pathway, an oncologically relevant concern flagged repeatedly on this site. For a self-limiting diet-transition symptom, that risk-to-evidence ratio is indefensible.

The Fosgonimeton Parallel: a Warning From the Clinic

The Dihexa mechanism is not just untested in humans — the one time a closely related mechanism was tested rigorously, it fell short. Fosgonimeton (ATH-1017), developed by Athira Pharma, is a small-molecule positive modulator of the HGF/MET system — conceptually the same lever Dihexa pulls. It was taken into a Phase 3 Alzheimer’s trial, LIFT-AD, and it missed its primary endpoint. A purpose-built, professionally manufactured HGF/MET modulator, tested properly, failed to deliver the hoped-for cognitive benefit.

Stack that against the keto evidence and the asymmetry is stark. Ketones show quiet, modest, replicated signals in the right clinical populations; the drug built on Dihexa’s pathway failed its pivotal trial; and Dihexa itself has never completed one. When someone with a week of keto fog is deciding between a spoonful of salt and a vial of research-grade peptide, this is the context that should settle it.

What Actually Works for Keto & Low-Carb Brain Fog

Pulling the evidence together, the practical playbook for keto brain fog is refreshingly boring — and that is a feature, not a bug:

  • Replace electrolytes first. Sodium above all, plus potassium and magnesium. This alone resolves most early keto fog, often within the hour.
  • Give adaptation two weeks. The scoping-review data say symptoms usually settle within 2–4 weeks. Ease training and protect sleep during the switch.
  • Formulate the diet properly. Enough calories, protein and micronutrients; watch for B12 and other gaps on very restrictive versions like carnivore.
  • If fog worsens the longer you stay strict, loosen up. The reversible case report is a real signal — adding carbohydrate back is a legitimate fix.
  • Rule out a medical cause. Persistent fog can flag thyroid disease, deficiencies, depression, sleep apnoea or menopause — a GP work-up beats any supplement.
  • Skip the unproven peptide. Layering an unlicensed research chemical onto a self-limiting diet symptom adds risk without evidence — the recurring lesson of the Dihexa vs nootropics comparison and the stacking guide.

Who Should Be Especially Cautious

Two cautions bear repeating. On the diet side, keto and very-low-carb eating are not for everyone: anyone with type 1 diabetes, on glucose-lowering or blood-pressure medication, pregnant or breastfeeding, or with a history of disordered eating should take medical advice before starting, as the risks (including hypoglycaemia and, rarely, ketoacidosis) are real. On the Dihexa side, the peptide should be avoided altogether — and especially by anyone with a personal or family history of cancer or any proliferative condition, anyone immunosuppressed, anyone pregnant, breastfeeding or planning pregnancy, and anyone who has not first had a proper work-up for the treatable causes of brain fog. The UK legal status page sets out why it cannot lawfully be sold to treat or enhance cognition in the first place.

The Bottom Line

“Keto brain fog” sounds alarming but is, in the overwhelming majority of cases, a temporary, electrolyte-driven adaptation symptom that clears with salt, fluids, adequate magnesium and a fortnight of patience. Beyond that first fortnight, ketones are a plausible and sometimes useful brain fuel — most convincingly in the glucose-starved brains of MCI and Alzheimer’s — but in healthy people the effect is mixed (“faster but less accurate”), and the elegant BHB–BDNF mechanism, so tempting to over-read, has not yet delivered a reliable cognition benefit in humans. If a natural ketone signal cannot clear that bar, an unlicensed peptide on a parallel pathway — with no human efficacy data, a pro-proliferative c-Met flag, and a closest clinical relative that failed its Alzheimer’s Phase 3 — certainly cannot. Fix the electrolytes, formulate the diet well, give it two weeks, treat any medical cause — and, as always on this site, the unglamorous, well-studied path wins and the research chemical comes last.

Frequently Asked Questions

Does keto cause brain fog?

Often, but usually only at the start. In the first days to two weeks of keto, many people get “keto flu” fog as the body switches from glucose to ketones. A 2025 scoping review found symptoms start within 2–3 days and resolve within 2–4 weeks, driven mostly by sodium and fluid loss — not brain damage. Once adapted, most people feel normal or sharper.

How do I fix keto brain fog fast?

Fluids plus electrolytes, with a focus on sodium. Falling insulin makes the kidneys excrete sodium and water, and that loss drives most early symptoms. Salt your food or drink broth, keep potassium and magnesium adequate, hydrate, ease off hard training and protect sleep — relief often comes within 30–90 minutes. No peptide required.

Do ketones actually improve brain function?

Sometimes — most clearly in brains that struggle to use glucose. In MCI and Alzheimer’s, ketones can bypass the brain’s glucose deficit, and a 2026 meta-analysis reports modest signals there. In healthy people it’s mixed: a 2026 study found keto made cognition faster but less accurate.

Is the BHB–BDNF story a reason to expect keto to build synapses?

Be cautious. Beta-hydroxybutyrate is a natural HDAC inhibitor that switches on BDNF in rodent hippocampus (Sleiman 2016), but a 2025 human study found raising BHB did not increase BDNF or improve cognition in people. The mechanism is real in animals; the human benefit is unproven — the same gap Dihexa faces, only wider.

Should I take Dihexa for keto brain fog?

No. Keto brain fog is usually a temporary electrolyte problem that resolves with salt, fluids and time at no cost. Dihexa is an unlicensed research chemical with no completed human trials for brain fog and a pro-proliferative c-Met concern — real risk to solve a problem that usually solves itself.

Can low-carb help diabetic brain fog?

Indirectly, yes — by improving blood-sugar control. A 2025 review found low-carb diets drove type 2 diabetes remission in up to ~62% at one year (falling to ~13% by five years), and steadier glucose can ease metabolic fog. That treats the underlying problem — it is not evidence for a peptide.

External Authoritative Sources Cited

Editorial statement: This article is part of a rolling 2026 clinical-context review series examining where Dihexa sits in the evidence hierarchy for specific concerns. We are not clinicians, and we do not sell Dihexa, supplements or diet products. This page is for education and is not medical advice. See the About page for our editorial approach and the disclaimer for legal scope. If brain fog is affecting your daily life, please speak to your GP.